Thursday, December 7, 2017

FDA petitioned to ban API that its reviewers say poses safety risks

The public advocacy group Public Citizen has petitioned the FDA to ban an API that it says agency reviewers determined posed safety risks to patients but is still showing up in compounded cancer treatments.
Post a Comment